) and integrated into these prognostic programs, but none of those makes an attempt succeeded in starting to be standard of treatment.94–ninety six Without a doubt, the Global Workshop on CLL (iwCLL) rules only advise assessing the IGHV position and existence/absence of TP53 aberrations in rou